MediciNova Inc (MNOV.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|52||2007||Independent Chairman of the Board|
|65||2014||President, Chief Executive Officer, Director|
|2016||Chief Financial Officer|
|47||2006||Vice President, Head - Japanese Office|
- BRIEF-Medicinova Announces Positive Top-Line Results From Clinical Trial Of MN-166 (ibudilast) In ALS
- BRIEF-Medicinova announces collaboration
- BRIEF-Medicinova announces positive top-line results from the Sprint-MS Phase 2B trial of MN-166 (ibudilast)
- BRIEF-Medicinova Inc files for potential mixed shelf of up to $200 million
- BRIEF-MediciNova completes enrollment in the phase 2 trial of MN-166 in methamphetamine dependence